3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Immediate Hypersensitivity: new trials by email Literature Review of Immediate Hypersensitivity trials Research Report on Immediate Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Peanut powder, Peanut extract, Placebo extract - Peanut Hypersensitivity, Food Hypersensitivity | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 21 | 2010-03-01 | 2017-04-07 |
| A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial Glycerinated peanut allergenic extract, Placebo for peanut extract (glycerin) - Food Hypersensitivity, Hypersensitivity | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2007-12-01 | 2019-08-21 |
| Oral Immunotherapy for Childhood Egg Allergy Egg oral immunotherapy, Control Group - Hypersensitivity, Immediate Hypersensitivity | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 55 | 2007-05-01 | 2017-12-13 |
Food Hypersensitivity (3) · Hypersensitivity, Immediate (3) · Hypersensitivity (2) · Peanut Hypersensitivity (2) · Egg Hypersensitivity (1)
Immune System Diseases (3) · Nut and Peanut Hypersensitivity (2) · Hypersensitivity (1)
Control Groups (1) · Glycerol (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Johns Hopkins University (1)
United States (3)
Robert Wood, MD (3) · David Fleischer, MD (2) · Stacie Jones, MD (2) · Wesley Burks, MD (2) · Hugh A. Sampson, MD (1) · Scott Sicherer, MD (1)
PMID 22808958, PMID 23265698, PMID 25528358, PMID 25656999, PMID 26924470
U19AI066738 (1)